-
Mashup Score: 22
Erectile dysfunction (ED) is a common side effect after prostate cancer stereotactic body radiotherapy (SBRT). We aimed to assess the correlation between the dose to the penile bulb (PB), internal pudendal arteries (IPA), and crura with the development of ED after ultra-hypofractionation as part of a phase II clinical trial of urethra-sparing prostate SBRT.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 52Long term results of a phase I dose escalation trial of ablative stereotactic body radiation therapy - 4 month(s) ago
Stereotactic body radiation therapy (SBRT) is increasingly used for oligometastatic disease as well as palliation, but treatment protocols for non-spine bone and nodal metastases are lacking, with a wide variety of schedules applied. Therefore, a prospective dose-escalation trial was initiated, involving 90 patients, among whom 52 (58%) had primary prostate tumors, 13 had breast tumors (14%), and 25 (28%) had other primary tumor types. All visible lymph node and/or non-spine bone oligometastases were treated in three consecutive cohorts: 5×7.0 Gy, 3×10.0 Gy, or 1×20.0 Gy.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet-
From @carole_mercier_ @piet_ost @ines_joye in #RedJournal: 90 patients with OMD were treated with SBRT to either 5x7, 3x10 or 1x20 Gy (DESTROY trial update). No late grade ≥3 toxicity & excellent LC at 4 years. Single-fraction SBRT was feasible and safe https://t.co/VlWxnayLpB https://t.co/FMkBjmPRMW
-
-
Mashup Score: 6
To predict the probability of grade ≥2 pneumonitis or dyspnea within 12 months of receiving conventionally fractionated or mildly hypofractionated proton beam therapy (PBT) for locally-advanced lung cancer using machine learning (ML).
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4NRG Oncology assessment on AI deep-learning based auto-segmentation for radiotherapy: current development, clinical consideration, and future direction - 5 month(s) ago
Deep learning neural networks (DLNN) in Artificial intelligence (AI) have been extensively explored for automatic segmentation in radiotherapy (RT). In contrast to traditional model-based methods, data-driven AI-based models for auto-segmentation have shown higher accuracy based on early publications in research lab settings or a controlled environment (single institution). Vendor-provided commercial AI models are made available as part of the integrated treatment planning system (TPS) or as a stand-alone tool that provides streamlined workflow interacting with the main TPS.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 39
The number of older adults with head-and-neck squamous cell carcinoma (HNSCC) is increasing, and treatment of these patients is challenging. Although cisplatin-based chemotherapy concomitantly with radiotherapy is considered standard regimen for patients with locoregionally advanced HNSCC, there is substantial real-world heterogeneity regarding concomitant chemotherapy in older HNSCC patients.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17
To report physician and patient-reported outcomes of patients with localized breast cancer treated with moderate versus ultra-hypofractionated whole breast irradiation (WBI) after breast-conserving surgery (BCS).
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13
The primary objectives were to describe the longitudinal course of sexual health in people undergoing curative (chemo)radiotherapy ([C]RT) for human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPVOPSCC) and identify factors associated with higher sexual satisfaction 12 months after [C]RT.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet-
From #RedJournal: Sexual health is affected during & after CRT in HPV OPC, returns to near baseline scores by 12 months. Sexual function considered a top survivorship priority by many HPV OPC survivors @lachiemcd @petermacres @petermacradonc @genesiscare. https://t.co/WFOFD9jVAB https://t.co/s771cYvXhs
-
-
Mashup Score: 0
Clinical trial participation continues to be low, slowing new cancer therapy development. Few strategies have been prospectively tested to address barriers to enrollment. We investigated the effectiveness of a physician audit and feedback report to improve clinical trial enrollment.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Clinical trial participation continues to be low, slowing new cancer therapy development. Few strategies have been prospectively tested to address barriers to enrollment. We investigated the effectiveness of a physician audit and feedback report to improve clinical trial enrollment.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Adding high-dose-rate (HDR) brachytherapy (BT) boost to external beam radiotherapy (EBRT) improves biochemical control but may affect patient-reported quality-of-life (QOL). We sought to determine long-term QOL outcomes for EBRT+BT versus EBRT alone.
Source: www.redjournal.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Read this new #RedJournal article from @Achard_Verane @Zillithomas on how Crura may be the new radiosensitive structure to protect when performing prostate SBRT in order to mitigate post SBRT erectile dysfunction https://t.co/rVELwmlXa4 https://t.co/suEw7B4rf7